What each actually is

Brand-name medications are pharmaceutical products that went through FDA new-drug approval, clinical trials, manufacturing standards, supply chain audits. Examples: Ozempic and Wegovy (semaglutide, Novo Nordisk), Mounjaro and Zepbound (tirzepatide, Eli Lilly), AndroGel (testosterone, AbbVie), Testim (testosterone, Endo).

Compounded medications are prepared by 503A or 503B compounding pharmacies under physician prescriptions, using the same active pharmaceutical ingredient (API) sourced from FDA-registered API manufacturers. The end product is the same molecule, semaglutide is semaglutide regardless of who fills the vial.

Why compounded exists

Three reasons:

Regulatory oversight

FactorBrand-nameCompounded (503A)
FDA drug approvalYesNo (compounding exemption)
State pharmacy licenseN/ARequired
FDA pharmacy registrationN/ARequired (503A or 503B)
USP <797> sterile prepEquivalentRequired
Identity / potency testingManufacturer batchPharmacy batch
Per-vial labelingGenericPatient-specific
LiabilityManufacturer + pharmacyPharmacy + physician

Both routes are regulated. The difference is who is doing the regulating and at what stage.

Dosing flexibility

Brand-name GLP-1 pens come in fixed doses: 0.25, 0.5, 1.0, 1.7, 2.4 mg for semaglutide. Compounded vials can be prescribed at any dose, 0.15, 0.4, 0.85, etc. This matters for slow titration in sensitive patients, microdosing for body composition (see), and custom protocols.

Same with TRT: brand-name testosterone gels and patches deliver fixed amounts. Compounded testosterone cypionate or enanthate can be prescribed at any weekly dose, with HCG and other adjuncts mixed to fit the protocol.

How to evaluate quality

Whether you're using brand or compounded, ask:

Reputable telehealth platforms, like OPTML, work exclusively with vetted U.S. 503A pharmacies. The difference between "compounded by a reputable U.S. pharmacy" and "compounded by an unverified source" is the difference between safe medicine and the gray-market peptides we covered in.

Bottom line

For most patients, properly compounded medications from reputable U.S. 503A pharmacies offer equivalent clinical quality to brand-name drugs with better dosing flexibility, particularly important for microdose protocols and slow titration. The brand-name premium pays for original drug development and maximum regulatory rigor. OPTML offers both pathways so patients can pick what fits, Novo Nordisk and Eli Lilly brand-name when that's the right call, and our compounded U.S. 503A protocols when flexibility or accessibility matters more.

Same
active molecule in compounded and brand
503A
FDA-registered pharmacy designation for patient-specific compounds
Same
active ingredient, same molecule, same effect
Pillar Guide · GLP-1 & Weight Loss
Read the full guide: GLP-1 Weight Loss: The Complete Guide →